一水西沙必利结构式
|
常用名 | 一水西沙必利 | 英文名 | CISAPRIDEMONOHYDRATE |
---|---|---|---|---|
CAS号 | 260779-88-2 | 分子量 | 483.96 | |
密度 | N/A | 沸点 | N/A | |
分子式 | C23H31ClFN3O5 | 熔点 | N/A | |
MSDS | 中文版 美版 | 闪点 | N/A | |
符号 |
GHS05 |
信号词 | Danger |
一水西沙必利用途Cisapride是直接的、选择性5-HT4 receptor激动剂,IC50为0.483 μM。也是间接的拟副交感神经药。 |
中文名 | 一水西沙必利 |
---|---|
英文名 | VZV0A4I38W |
英文别名 | 更多 |
描述 | 一水西沙必利是一种口服有效的5-HT4受体激动剂和hERG抑制剂。一水西沙必利是一种促动力剂,可促进或恢复整个胃肠道的运动。一水西沙必利通过一种间接机制刺激胃肠运动活动,该机制涉及由肠肌间神经丛中的节后神经末梢介导的乙酰胆碱释放[1][2]。 |
---|---|
相关类别 | |
靶点 |
5-HT4 Receptor:0.14 μM (EC50) |
参考文献 |
[1]. Wiseman, L.R., Faulds, D. Cisapride. Drugs 47, 116–152 (1994). |
分子式 | C23H31ClFN3O5 |
---|---|
分子量 | 483.96 |
外观性状 | 粉末 |
储存条件 | -20℃ |
符号 |
GHS05 |
---|---|
信号词 | Danger |
危害声明 | H318 |
警示性声明 | P280-P305 + P351 + P338 |
个人防护装备 | dust mask type N95 (US);Eyeshields;Gloves |
危险品运输编码 | NONH for all modes of transport |
RTECS号 | CU9372000 |
Acute cardiotoxicity evaluation of the marine biotoxins OA, DTX-1 and YTX.
Toxins (Basel.) 7 , 1030-47, (2015) Phycotoxins are marine toxins produced by phytoplankton that can get accumulated in filter feeding shellfish. Human intoxication episodes occur due to contaminated seafood consumption. Okadaic acid (O... |
|
High-Content Assay Multiplexing for Toxicity Screening in Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Hepatocytes.
Assay Drug Dev. Technol. 13 , 529-46, (2015) Cell-based high-content screening (HCS) assays have become an increasingly attractive alternative to traditional in vitro and in vivo testing in pharmaceutical drug development and toxicological safet... |
|
A pharmacologically validated, high-capacity, functional thallium flux assay for the human Ether-à-go-go related gene potassium channel.
Assay Drug Dev. Technol. 8 , 714-26, (2010) The voltage-gated potassium channel, human Ether-à-go-go related gene (hERG), represents the molecular component of IKr, one of the potassium currents involved in cardiac action potential repolarizati... |
CISAPRIDE MONOHYDRATE |
UNII:VZV0A4I38W |
Benzamide, 4-amino-5-chloro-N-[(3S,4R)-1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl]-2-methoxy-, hydrate (1:1) |
4-Amino-5-chloro-N-{(3S,4R)-1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-2-methoxybenzamide hydrate (1:1) |
VZV0A4I38W |